ClinicalTrials.Veeva

Menu

Evaluation of Rare and Complex Tumours of the Thoraco-Abdominal and Soft Tissue District (RAC)

S

Scientific Institute for Research Hospitalization and Healthcare (IRCCS)

Status

Enrolling

Conditions

Rare Malignant Neoplasm

Treatments

Other: diagnosis, surgery, drugs for rare neoplasms

Study type

Observational

Funder types

Other

Identifiers

NCT06872853
RAC - 1058/2020/OSS/AOUBo

Details and patient eligibility

About

The goal of this observational study is to collect structured data about diagnosis, treatment and follow-up of rare and highly complex neoplasms.

The study has a rerospective part that will consist in gathering data on patients accessing IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di S. Orsola from 01/01/2000 to 28/09/2017 and a prospective one ranging from 29/09/2017 to 31/12/2025.

Enrollment

1,100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with histologic diagnosis of rare or highly complex malignant neoplasm
  • informed consent

Exclusion criteria

  • none

Trial contacts and locations

2

Loading...

Central trial contact

Maria A Pantaleo, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems